Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy

NCT02375334 · clinicaltrials.gov ↗

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Support Staff Left Institution

Conditions

Malignant Glioma
Myelosuppression

Interventions

OTHER: Medical Chart Review

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]